A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer.
Mercedes Martinez Villacampa
No relevant relationships to disclose
Jaume Capdevila
No relevant relationships to disclose
Jose Luis Manzano
No relevant relationships to disclose
Carles Pericay
No relevant relationships to disclose
Ramon Salazar
No relevant relationships to disclose
Carlos López-López
No relevant relationships to disclose
Ferran Losa
No relevant relationships to disclose
M. José Safont
No relevant relationships to disclose
Auxiliadora Gomez
No relevant relationships to disclose
Vicente Alonso
No relevant relationships to disclose
M. Pilar Escudero
No relevant relationships to disclose
Javier Gallego Plazas
No relevant relationships to disclose
Javier Sastre
No relevant relationships to disclose
Cristina Gravalos Castro
No relevant relationships to disclose
Sebastiano Biondo
No relevant relationships to disclose
Amalia Palacios
No relevant relationships to disclose
Enrique Aranda
Consultant or Advisory Role - Merck Serono; Roche